Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Severe X-linked mitochondrial encephalomyopathy is an extremely rare mitochondrial respiratory chain disease resulting in a neurodegenerative disorder characterized by psychomotor delay, hypotonia, areflexia, muscle weakness and wasting in the two patients reported to date.
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 6:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Features include always present findings: Low muscle tone (hypotonia), Muscle weakness, Ragged-red muscle fibers, and Increased circulating pyruvate concentration and others; and common findings: Seizure, Polyneuropathy, Irritability, and Tongue fasciculations and others. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 11 | Seizure, Polyneuropathy, Irritability |
Muscles | 6 | Low muscle tone (hypotonia), Tongue fasciculations, Muscle weakness |
Lab test results | 3 | Increased circulating pyruvate concentration, Increased circulating lactate concentration, Decreased activity of mitochondrial complex IV |
Bones and joints | 1 | Skeletal muscle atrophy |
Lungs and breathing | 1 | Difficulty breathing due to muscle weakness (respiratory insufficiency due to muscle weakness) |
Age of onset: infancy.
AIFM1 encodes apoptosis inducing factor mitochondria associated 1 (613 aa). Functions both as NADH oxidoreductase and as regulator of apoptosis. Highest expression in Adrenal Gland (62.8 TPM) and Cells EBV-transformed lymphocytes (58.3 TPM).
Severe X-linked mitochondrial encephalomyopathy is associated with mutations in the AIFM1 gene on chromosome X.
AIFM1 is classified as a druggable target (Druggable Genome category) with score 5.2.
Genetic testing for AIFM1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for severe X-linked mitochondrial encephalomyopathy has been reported in the published literature.
Phenotype severity distribution: 9 always present features, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for severe X-linked mitochondrial encephalomyopathy.
32 publications have been identified in PubMed for severe X-linked mitochondrial encephalomyopathy. Research spans Basic Science / Preclinical (56%), Review / Meta-Analysis (16%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 18 | 56% |
Research summaries | 5 | 16% |
Patient case studies | 4 | 13% |
Testing and diagnosis research | 2 | 6% |
New treatment approaches | 2 | 6% |
Disease patterns and progression | 1 | 3% |
Demir M (2026). [PMID: 41592542](https://pubmed.ncbi.nlm.nih.gov/41592542/). *Allergy Asthma Immunol Res*. [Epidemiology / Natural History]
Thoma F (2026). [PMID: 41512010](https://pubmed.ncbi.nlm.nih.gov/41512010/). *PLoS Genet*. [Basic Science / Preclinical]
Villafan-Bernal JR (2026). [PMID: 41614925](https://pubmed.ncbi.nlm.nih.gov/41614925/). *Curr Issues Mol Biol*. [Review / Meta-Analysis]
Torres-Haro A (2026). [PMID: 41701386](https://pubmed.ncbi.nlm.nih.gov/41701386/). *World J Microbiol Biotechnol*. [Basic Science / Preclinical]
Catinelli BB (2026). [PMID: 41308893](https://pubmed.ncbi.nlm.nih.gov/41308893/). *Biochim Biophys Acta Mol Basis Dis*. [Basic Science / Preclinical]
Tang B (2026). [PMID: 41608526](https://pubmed.ncbi.nlm.nih.gov/41608526/). *Research (Wash D C)*. [Case Report / Case Series]
Gao X (2026). [PMID: 41897749](https://pubmed.ncbi.nlm.nih.gov/41897749/). *Foods*. [Basic Science / Preclinical]
Molina-Berenguer M (2026). [PMID: 41998139](https://pubmed.ncbi.nlm.nih.gov/41998139/). *EMBO Mol Med*. [Gene Therapy / Novel Therapeutics]
Malyutina A (2026). [PMID: 41782446](https://pubmed.ncbi.nlm.nih.gov/41782446/). *Dis Model Mech*. [Basic Science / Preclinical]
Mihalikova D (2025). [PMID: 39351780](https://pubmed.ncbi.nlm.nih.gov/39351780/). *Eur J Prev Cardiol*. [Basic Science / Preclinical]